Similarly, in COVID‐19‐associated pulmonary fibrosis, SLC16A4 may mediate intercellular lactate signaling, activating fibrosis‐related pathways, such as fibroblast proliferation and ECM accumulation. This evidence concerns the gene SLC16A4 and pulmonary fibrosis.